Abstract:BACKGROUND AND AIMS:Blood and/or liver fatty acid contents of healthy subjects and non-alcoholic fatty liver disease (NAFLD) patients have shown inconsistent associations. In addition, the results of randomized controlled trials (RCTs) in relation to the effects of n-3 polyunsaturated fatty acid (PUFA) supplementation on alanine aminotransferase (ALT), aspartate aminotransferase (AST), liver fat, triglyceride (TAG) and fasting glucose levels are inconsistent. The present study aimed to investigate the differences of fatty acid content in the blood and/or liver tissue between healthy subjects and NAFLD patients, and to quantify the benefits of n-3 PUFA therapy in NAFLD patients.METHODS:A systematic literature search was performed up to November 2016 using PubMed and Scopus databases. The differences of fatty acid content between cases and controls were calculated as weighted mean differences (WMD) by using a random-effects model. The intervention effects of RCTs were calculated as WMD for net changes in ALT, AST, liver fat, TAG and fasting glucose levels, respectively. Meta-regression with restricted maximum likelihood estimation was used to evaluate a potential linear relationship between confounding factors and effect sizes. Generalized least square was performed for dose-response analysis.RESULTS:Ten eligible case-control studies and 11 RCTs were included. The pooled estimates of case-control studies showed that blood and/or liver docosahexaenoic acid (DHA) content was significantly higher in the controls compared with cases. The pooled estimates of RCTs showed that n-3 PUFA supplementation significantly reduced the ALT (-7.53 U/L; 95% CI: -9.98, -5.08 U/L), ASL (-7.10 U/L, 95% CI: -11.67, -2.52 U/L) and TAG (-36.16 mg/dL, 95% CI: -49.15, -23.18 mg/dL) concentrations, and marginally reduced the liver fat content (-5.11%, 95% CI: -10.24, 0.02%, P = 0.051), but not fasting glucose. Dose-response analysis of RCTs showed that 1 g per day increment of eicosapentaenoic acid (EPA)+DHA was associated with a 3.14 U/L, 2.43 U/L, 2.74% and 9.97 mg/dL reduction in ALT (95% CI: -5.25, -1.02 U/L), AST (95% CI: -3.90, -0.90 U/L), liver fat (95% CI: -4.32, -1.16%) and TAG (95% CI: -14.47, -5.48 mg/dL) levels, respectively.CONCLUSIONS:The present meta-analysis provides substantial evidence that n-3 PUFA supplementation, especially DHA, has a favorable effect in treatment of NAFLD.

Effects of Blended Oils with Different N-6/N-3 Polyunsaturated Fatty Acid Ratios on High-Fat Diet-Induced Metabolic Disorders and Hepatic Steatosis in Rats

Low n-6/n-3 PUFA Ratio Improves Lipid Metabolism, Inflammation, Oxidative Stress and Endothelial Function in Rats Using Plant Oils as n-3 Fatty Acid Source

Effect of Lard or Plus Soybean Oil on Markers of Liver Function in Healthy Subjects: A Randomized Controlled-Feeding Trial

Effects of Different N-6/N-3 Polyunsaturated Fatty Acids Ratios on Lipid Metabolism in Patients with Hyperlipidemia: a Randomized Controlled Clinical Trial.

Effect of Lard Plus Soybean Oil on Blood Pressure and Other Cardiometabolic Risk Factors in Healthy Subjects: a Randomized Controlled-Feeding Trial

Beneficial effects of monounsaturated fatty acid-rich blended oils with an appropriate polyunsaturated/saturated fatty acid ratio and a low n-6/n-3 fatty acid ratio on the health of rats

Effect of different oil on lipid metabolism and hepatic steatosis in rats

Effects of n-3 polyunsaturated fatty acids high fat diet intervention on the synthesis of hepatic high-density lipoprotein cholesterol in obesity-insulin resistance rats

Normal Fat Intake with High MUFA Content and an Appropriate SFA/MUFA/PUFA Ratio Improved the Health of Rats

Different N-6/N-3 Polyunsaturated Fatty Acid Ratios Affect Postprandial Metabolism in Normal and Hypertriglyceridemic Rats

Fatty Acid and Non-Alcoholic Fatty Liver Disease: Meta-analyses of Case-Control and Randomized Controlled Trials.

Effects of Chinese Dietary Pattern of Fat Content, n-6/n-3 Polyunsaturated Fatty Acid Ratio, and Cholesterol Content on Lipid Profile in Rats.

Effect of Different Fatty Acid Compositions on Blood Lipid of Rats

Differential effects of Chinese high-fat dietary habits on lipid metabolism: mechanisms and health implications

Differential Responses Of Hepatic Endoplasmic Reticulum Stress And Inflammation In Diet-Induced Obese Rats With High-Fat Diet Rich In Lard Oil Or Soybean Oil

Comparison of the Effects of Monounsaturated Fatty Acids and Polyunsaturated Fatty Acids on Liver Lipid Disorders in Obese Mice

Benefits of blended oil consumption over other sources of lipids on the cardiovascular system in obese rats

[Effects of Ω-3 Polyunsaturated Fatty Acids from Different Sources on Glucolipid Metabolism in Type 2 Diabetic Patients with Dyslipidemia].

Effects of Lard Enriched with N-3 Polyunsaturated Fatty Acids on Serum Lipid Composition in Rats

EFFECTS OF FISH OIL WITH HIGH DHA/EPA AND TRIGLYCERIDES ON LIPID METABOLISM IN FATTY LIVER RATS

Effects of Omega-3 Fatty Acid in Nonalcoholic Fatty Liver Disease: A Meta-Analysis